SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company's total revenue for the quarter ended September 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 11848.50 millions.A slender decline of -9.06% was recorded to Rs. 424.40  millions from Rs. 466.70 millions in the corresponding previous quarter.Operating Profit saw a handsome growth to 1937.20 millions from 1864.10 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 11848.50 11580.30 2.32 23017.80 22656.80 1.59 48123.90 57734.50 -16.65
Other Income 118.90 59.00 101.53 211.90 126.10 68.04 474.20 159.50 197.30
PBIDT 1937.20 1864.10 3.92 3644.10 3210.00 13.52 7973.00 14977.10 -46.77
Interest 446.90 378.00 18.23 855.80 712.70 20.08 1508.20 1457.00 3.51
PBDT 1490.30 1486.10 0.28 2788.30 2497.30 11.65 6464.80 13520.10 -52.18
Depreciation 909.40 854.00 6.49 1819.40 1692.70 7.49 3450.10 3005.80 14.78
PBT 580.90 632.10 -8.10 968.90 804.60 20.42 3014.70 10514.30 -71.33
TAX 156.50 165.40 -5.38 256.70 207.20 23.89 777.70 2910.50 -73.28
Deferred Tax -63.20 -17.60 259.09 -135.60 -40.10 238.15 -101.70 202.70 -150.17
PAT 424.40 466.70 -9.06 712.20 597.40 19.22 2237.00 7603.80 -70.58
Equity 1078.30 1077.30 0.09 1078.30 1077.30 0.09 1077.90 1077.30 0.06
PBIDTM(%) 16.35 16.10 1.57 15.83 14.17 11.74 16.57 25.94 -36.13

Laurus Labs Share Price

1113.55 -0.95 (-0.09%)
22-Apr-2026 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.20
Dr. Reddys Lab 1220.70
Cipla 1233.85
Zydus Lifesciences 931.20
Lupin 2307.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×